İNANÇ, G. N. Et Al. 2017. Is There Any Difference in RA Patients for Methotrexate Use Vs. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmards in Turkbio Registry. ARTHRITIS RHEUMATOLOGY .

İNANÇ, G. N., ÖZEN, G., YALÇINKAYA, Y., DALKILIÇ, H. E., KOCA, S. S., CAN, G., ... KARATAŞ, A.(2017). Is There Any Difference in RA Patients for Methotrexate Use Vs. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmards in Turkbio Registry . ARTHRITIS RHEUMATOLOGY

İNANÇ, GÜZİDE Et Al. "Is There Any Difference in RA Patients for Methotrexate Use Vs. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmards in Turkbio Registry," ARTHRITIS RHEUMATOLOGY, 2017

İNANÇ, GÜZİDE N. Et Al. "Is There Any Difference in RA Patients for Methotrexate Use Vs. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmards in Turkbio Registry." ARTHRITIS RHEUMATOLOGY , 2017

İNANÇ, G. N. Et Al. (2017) . "Is There Any Difference in RA Patients for Methotrexate Use Vs. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmards in Turkbio Registry." ARTHRITIS RHEUMATOLOGY .

@conferencepaper{conferencepaper, author={GÜZİDE NEVSUN İNANÇ Et Al. }, title={Is There Any Difference in RA Patients for Methotrexate Use Vs. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmards in Turkbio Registry}, congress name={ARTHRITIS RHEUMATOLOGY}, city={}, country={}, year={2017}}